Mirena and Gilenya drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mirena (levonorgestrel) and Gilenya (fingolimod). Common drug interactions include muscular weakness among females and foetal arrhythmia among males.

The phase IV clinical study analyzes what interactions people have when they take Mirena and Gilenya. It is created by eHealthMe based on reports of 97 people who take the same drugs from the FDA, and is updated regularly.

What is Mirena?

Mirena has active ingredients of levonorgestrel. It is often used in birth control. eHealthMe is studying from 145,266 Mirena users. Check the latest studies of Mirena.

What is Gilenya?

Gilenya has active ingredients of fingolimod. It is often used in multiple sclerosis. eHealthMe is studying from 111,893 Gilenya users. Check the latest studies of Gilenya.



On Jul, 05, 2026

97 people who take Mirena and Gilenya together, and have interactions are studied.

Mirena and Gilenya drug interactions.

What are the common drug interactions of Mirena and Gilenya, by gender? *:

female:

  1. Muscular weakness (muscle weakness)
  2. Device dislocation
  3. Hypoaesthesia (reduced sense of touch or sensation)
  4. Abdominal pain
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Dyspnoea (difficult or laboured respiration)
  7. Eye disorder
  8. Ocular hyperaemia (an abnormally large amount of blood in eye)
  9. Palpitations (feelings or sensations that your heart is pounding or racing)
  10. Panic attack

male:

  1. Foetal arrhythmia (abnormal rate or rhythm of the foetus heartbeat)
  2. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)

What are the common drug interactions of Mirena and Gilenya, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Fatigue (feeling of tiredness)
  2. Dizziness
  3. Oropharyngeal pain
  4. Renal cancer (cancer of kidney)
  5. Abdominal pain
  6. Clostridium test positive
  7. Nasopharyngitis (inflammation of the nasopharynx)
  8. Nausea (feeling of having an urge to vomit)
  9. Asthenia (weakness)
  10. Back pain

30-39:

  1. Urinary tract infection
  2. Hypotension (abnormally low blood pressure)
  3. Anion gap increased
  4. Basophil count decreased
  5. Blood alkaline phosphatase increased
  6. Blood calcium increased
  7. Blood creatinine increased
  8. Blood glucose increased
  9. Blood immunoglobulin g increased
  10. Carbon dioxide decreased

40-49:

  1. Procedural pain
  2. Psychomotor hyperactivity (feelings of extreme restlessness)
  3. Red blood cell count decreased
  4. Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)
  5. Tinea pedis (a contagious skin infection caused by the ringworm fungus)
  6. Uterine pain
  7. Vaginal haemorrhage (vaginal bleeding)
  8. Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)
  9. Visual impairment
  10. Weight decreased

50-59:

  1. Headache (pain in head)
  2. Alopecia (absence of hair from areas of the body)
  3. Nausea (feeling of having an urge to vomit)
  4. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  5. White blood cell count decreased
  6. Breast fibroma (fibroadenomas of the breast are small, solid, rubbery, noncancerous, harmless lumps composed of fibrous and glandular tissue)
  7. Partial seizures (seizures which affect only a part of the brain at onset)
  8. Device dislocation
  9. Gait disturbance
  10. Implant site extravasation

60+:

n/a

What are the existing conditions these people have? *

  1. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 12 people, 12.37%
  2. Depression: 10 people, 10.31%
  3. Pain: 9 people, 9.28%
  4. Migraine (headache): 8 people, 8.25%
  5. Stress And Anxiety: 6 people, 6.19%
  6. Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 6 people, 6.19%
  7. Fatigue (feeling of tiredness): 6 people, 6.19%
  8. Suicidal Ideation: 5 people, 5.15%
  9. Seasonal Allergy (allergic condition due to certain season): 5 people, 5.15%
  10. Rickets (softening of bones): 5 people, 5.15%

* Approximation only. Some reports may have incomplete information.

Do you take Mirena and Gilenya?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Mirena and Gilenya:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mirena:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Gilenya:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mirena and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gilenya and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on levonorgestrel and fingolimod (the active ingredients of Mirena and Gilenya, respectively), and Mirena and Gilenya (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: